AstraZeneca Pharmaceuticals LP recalls NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZene…
- Recall date
- June 10, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1141-2015
- FDA classification
- Class II
- Brand / firm
- AstraZeneca Pharmaceuticals LP
- Sold / distributed
- Nationwide to wholesalers for further distribution at the retail level.
Why it was recalled
Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.
Get recall alerts
Free email alert whenever AstraZeneca Pharmaceuticals LP has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: AstraZeneca Pharmaceuticals LP